US20150178470A1 - Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products - Google Patents

Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products Download PDF

Info

Publication number
US20150178470A1
US20150178470A1 US14/417,265 US201314417265A US2015178470A1 US 20150178470 A1 US20150178470 A1 US 20150178470A1 US 201314417265 A US201314417265 A US 201314417265A US 2015178470 A1 US2015178470 A1 US 2015178470A1
Authority
US
United States
Prior art keywords
patient
combination
questions
substances
feedback
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/417,265
Other languages
English (en)
Inventor
Johan Cederlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCIENTIFICMED SWEDEN AB
Original Assignee
SCIENTIFICMED SWEDEN AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCIENTIFICMED SWEDEN AB filed Critical SCIENTIFICMED SWEDEN AB
Assigned to SCIENTIFICMED SWEDEN AB reassignment SCIENTIFICMED SWEDEN AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CEDERLUND, JOHAN
Publication of US20150178470A1 publication Critical patent/US20150178470A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G06F19/363—
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for specific business sectors, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Social work

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
US14/417,265 2012-07-24 2013-07-12 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products Abandoned US20150178470A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1250893-3 2012-07-24
SE1250893 2012-07-24
PCT/SE2013/050896 WO2014017971A2 (fr) 2012-07-24 2013-07-12 Effet clinique amélioré de produits pharmaceutiques obtenu à l'aide d'un outil de communication associé à un composé constitué de plusieurs produits pharmaceutiques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2013/050896 A-371-Of-International WO2014017971A2 (fr) 2012-07-24 2013-07-12 Effet clinique amélioré de produits pharmaceutiques obtenu à l'aide d'un outil de communication associé à un composé constitué de plusieurs produits pharmaceutiques

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/160,519 Continuation US11004545B2 (en) 2012-07-24 2018-10-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products

Publications (1)

Publication Number Publication Date
US20150178470A1 true US20150178470A1 (en) 2015-06-25

Family

ID=49997939

Family Applications (5)

Application Number Title Priority Date Filing Date
US14/417,265 Abandoned US20150178470A1 (en) 2012-07-24 2013-07-12 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US16/160,519 Active US11004545B2 (en) 2012-07-24 2018-10-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US17/301,828 Abandoned US20210233625A1 (en) 2012-07-24 2021-04-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US17/301,826 Abandoned US20210233624A1 (en) 2012-07-24 2021-04-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US17/301,829 Abandoned US20210233626A1 (en) 2012-07-24 2021-04-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products

Family Applications After (4)

Application Number Title Priority Date Filing Date
US16/160,519 Active US11004545B2 (en) 2012-07-24 2018-10-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US17/301,828 Abandoned US20210233625A1 (en) 2012-07-24 2021-04-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US17/301,826 Abandoned US20210233624A1 (en) 2012-07-24 2021-04-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US17/301,829 Abandoned US20210233626A1 (en) 2012-07-24 2021-04-15 Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products

Country Status (5)

Country Link
US (5) US20150178470A1 (fr)
EP (1) EP2877949A4 (fr)
JP (1) JP2015529894A (fr)
CA (1) CA2879941A1 (fr)
WO (1) WO2014017971A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170091419A1 (en) * 2015-09-25 2017-03-30 Accenture Global Solutions Limited Monitoring and treatment dosage prediction system
US20170169175A1 (en) * 2015-09-15 2017-06-15 Michael Graff Patient care management system
USD900126S1 (en) * 2018-08-28 2020-10-27 Nitto Denko Corporation Display screen or portion thereof with graphical user interface

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021193474A (ja) * 2020-06-07 2021-12-23 株式会社カケハシ 薬剤交付後の服薬指導を継続的に行うための装置、方法及びプログラム
IL278092A (en) * 2020-10-15 2022-05-01 Feelbetter Ltd Automated medication regimen management and intervention
WO2022146930A1 (fr) * 2020-12-28 2022-07-07 Manifold Inc. Système et procédé de prédiction de résultats cliniques et d'optimisation d'interventions de santé
KR102542675B1 (ko) * 2022-04-11 2023-06-14 주식회사 올라운드닥터스 항암제의 부작용 치료를 위한 원격 치료 서버 및 그에 관한 방법
CN117637188B (zh) * 2024-01-26 2024-04-09 四川省肿瘤医院 基于数字化平台的肿瘤化疗反应监测方法、介质及系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036683A1 (en) * 2000-05-01 2003-02-20 Kehr Bruce A. Method, system and computer program product for internet-enabled, patient monitoring system

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5572421A (en) 1987-12-09 1996-11-05 Altman; Louis Portable medical questionnaire presentation device
US5633910A (en) * 1994-09-13 1997-05-27 Cohen; Kopel H. Outpatient monitoring system
US7251609B1 (en) * 1999-04-29 2007-07-31 The Trustees Of Boston University Method for conducting clinical trials over the internet
US20010034639A1 (en) * 2000-03-10 2001-10-25 Jacoby Jennifer B. System and method for matching aggregated user experience data to a user profile
WO2002009004A1 (fr) * 2000-07-21 2002-01-31 Surromed, Inc. Questionnaire medical informatise avec questions presentees dynamiquement
CA2420400A1 (fr) * 2000-08-24 2002-02-28 Veritas Medicine, Inc. Recrutement d'un patient pour un essai clinique
US6315720B1 (en) * 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
US20030036923A1 (en) * 2001-05-18 2003-02-20 Waldon R. Forrest Patient compliance and monitoring system
US20020192159A1 (en) * 2001-06-01 2002-12-19 Reitberg Donald P. Single-patient drug trials used with accumulated database: flowchart
US20030115214A1 (en) * 2001-12-17 2003-06-19 Nir Essar Medical reporting system and method
US7311666B2 (en) * 2004-07-10 2007-12-25 Trigeminal Solutions, Inc. Apparatus for collecting information
JP4667915B2 (ja) * 2005-03-11 2011-04-13 パナソニック株式会社 処方監査支援システム及び処方監査支援方法
JP4648142B2 (ja) * 2005-09-20 2011-03-09 大日本印刷株式会社 調剤医薬品等受け取りシステム
EP1941468A4 (fr) * 2005-10-07 2011-02-09 Bluepoint Internat Pty Ltd Distribution de produits de diffusion restreinte
US20070250345A1 (en) * 2006-04-24 2007-10-25 James Walker Electronic medical record system, method, and computer process for the testing, diagnosis, and treatment of sleep disorders
US20080109252A1 (en) 2006-11-08 2008-05-08 Lafountain Andrea Predicting patient compliance with medical treatment
US8540516B2 (en) 2006-11-27 2013-09-24 Pharos Innovations, Llc Optimizing behavioral change based on a patient statistical profile
US7953613B2 (en) * 2007-01-03 2011-05-31 Gizewski Theodore M Health maintenance system
US8342172B2 (en) * 2007-02-05 2013-01-01 The Brigham And Women's Hospital, Inc. Instrumented metered-dose inhaler and methods for predicting disease exacerbations
CA2702408C (fr) * 2007-10-12 2019-08-06 Patientslikeme, Inc. Procede auto-ameliore d'utilisation de communautes en ligne pour predire des resultats cliniques
WO2009063209A1 (fr) * 2007-11-15 2009-05-22 Patients Direct Limited Système et procédé de surveillance de commercialisation
US8380531B2 (en) * 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
WO2010042444A1 (fr) * 2008-10-06 2010-04-15 Merck Sharp & Dohme Corp. Dispositifs et procédés pour déterminer la propension d’un patient à se conformer à une ordonnance de médication
US8725530B2 (en) * 2008-12-08 2014-05-13 Mastodon, Llc Systems, methods, and apparatus for use in gathering and providing healthcare information
JP2012514799A (ja) * 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
US20110209065A1 (en) * 2010-02-23 2011-08-25 Farmacia Electronica, Inc. Method and system for consumer-specific communication based on cultural normalization techniques
US20120030231A1 (en) * 2010-07-28 2012-02-02 Charles Austin Cropper Accessing Personal Records Without Identification Token
US20130096944A1 (en) * 2011-10-13 2013-04-18 The Board of Trustees of the Leland Stanford, Junior, University Method and System for Ontology Based Analytics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036683A1 (en) * 2000-05-01 2003-02-20 Kehr Bruce A. Method, system and computer program product for internet-enabled, patient monitoring system

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170169175A1 (en) * 2015-09-15 2017-06-15 Michael Graff Patient care management system
US20170091419A1 (en) * 2015-09-25 2017-03-30 Accenture Global Solutions Limited Monitoring and treatment dosage prediction system
US10657224B2 (en) * 2015-09-25 2020-05-19 Accenture Global Solutions Limited Monitoring and treatment dosage prediction system
USD900126S1 (en) * 2018-08-28 2020-10-27 Nitto Denko Corporation Display screen or portion thereof with graphical user interface

Also Published As

Publication number Publication date
EP2877949A2 (fr) 2015-06-03
US11004545B2 (en) 2021-05-11
JP2015529894A (ja) 2015-10-08
US20190122749A1 (en) 2019-04-25
WO2014017971A3 (fr) 2014-03-20
US20210233625A1 (en) 2021-07-29
WO2014017971A2 (fr) 2014-01-30
CA2879941A1 (fr) 2014-01-30
US20210233626A1 (en) 2021-07-29
US20210233624A1 (en) 2021-07-29
EP2877949A4 (fr) 2017-05-10

Similar Documents

Publication Publication Date Title
US11004545B2 (en) Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
US20150193597A1 (en) Pharmaceutical product and communication tool
US20130304502A1 (en) Pharmaceutical product and communication tool
Korcegez et al. Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from Northern Cyprus: a randomized controlled trial
US10867695B2 (en) System and method for comprehensive health and wellness mobile management
Sapkota et al. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes—impact on adherence
Sav et al. Burden of treatment for chronic illness: a concept analysis and review of the literature
US20200230145A1 (en) Pharmaceutical product and communication tool
Dean et al. Framework for continuous palliative sedation therapy in Canada
US20180358117A1 (en) System and Method for Personal Health Information Exchange
van Esch et al. Effect of prophylactic subcutaneous scopolamine butylbromide on death rattle in patients at the end of life: the SILENCE randomized clinical trial
Wasserman et al. Oral immunotherapy for food allergy: the FAST perspective
Oliveira et al. Knowledge and attitudes of patients with diabetes mellitus in a primary health care system
Reach Obedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients
Hajek et al. Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial
Mogueo et al. Effectiveness of interventions based on patient empowerment in the control of type 2 diabetes in sub‐Saharan Africa: A review of randomized controlled trials
Swe et al. Improving adherence in type 2 diabetes
Laven et al. How pharmacists can encourage patient adherence to medicines
Doggrell Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes?
Weeden et al. Psychotropic drug treatments for people with autism and other developmental disorders: A primer for practicing behavior analysts
CN112233765A (zh) 一种重复用药智能分析的方法、系统和设备
US20150178471A1 (en) Improved clinical effect of pharmaceutical products using communication tool and life-style factors
Hammouda Overcoming barriers to diabetes control in geriatrics
US20230317230A1 (en) Method for treating obesity
Zheng Ethical Implications of Biohacking as Activism: Democratized Health Care, Danger, or What?

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIENTIFICMED SWEDEN AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CEDERLUND, JOHAN;REEL/FRAME:035011/0615

Effective date: 20150218

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION